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Background/aim: Cerebral Palsy (CP) is the most frequent cause of physical disability in childhood. CP causes primary deficits such
as impairments in muscle tone, muscle weakness, problems in selective motor control and secondary deficits such as contractures
and deformities. These deficits lead to motor disorders during movement causing limitations in gait. Sixty percent of children with
CP can walk independently despite these problems, however, they present with various gait abnormalities. Gait analysis is used in the
quantitative assessment of gait disturbances providing functional diagnosis, assessment for treatment, planning, and monitoring of
progress. G-Walk is a wearable sensor device which provides quantitative gait analysis via spatiotemporal parameters and pelvic girdle
angles. In literature, there is no study investigating the reliability of the G-Walk in children with CP. The purpose of this study was to
confirm the test-retest reliability of a commercially available body-worn sensor ‘BTS G-WALK sensor system’ for spatiotemporal gait
parameters in children with CP.
Materials and methods: Fifty-four children with CP (mean age: 9.19 ± 3.49 years), Gross Motor Function Classification System
(GMFCS) level I-II completed the test-retest protocol with 5 days between tests. The test-retest reliability was calculated using intra-class
correlation coefficients (ICC). Minimal detectable changes were calculated using standard error measurements.
Results: According to the analysis, ICC varied from 0.799 to 0.977 in all of the gait parameters. The statistical analysis showed that all
G-Walk parameters’ measurements were found to have almost perfect test-retest reliability.
Conclusion: The G-Walk was found to be reliable in gait parameters for children with CP between ages 5 and 15, in GMFCS level I-II.
A gait analysis carried out with the G-Walk system is a reliable method to assess gait in children with CP in a clinical setting.
Key words: Cerebral palsy, gait analysis, reliability, wearable sensor device

1. Introduction
Cerebral palsy (CP) is caused by a nonprogressive injury
in the developing brain, which leads to problems in
functional mobility, posture, neuro-musculoskeletal
functions, and gait [1,2]. Around 75% of children with CP
are ambulatory and 60% of children with CP are able to
walk independently however, they have gait problems such
as excessive knee flexion, stiff knee, crouch gait, or equinus
which affects the quality of gait [3,4].
Normal gait function is one of the most complicated
dynamic tasks of the musculoskeletal and neurological
systems. In cerebral palsy, primary disorders of these
systems may lead to secondary disturbances in gait. Gait
analysis is used in the quantitative assessment of gait
disturbances providing functional diagnosis, assessment
for treatment, planning, and monitoring of progress [5]. In
gait analysis, a large amount of quantitative data concerning

the gait characteristics of a patient is analyzed. The
assessment of these data can be performed via standardized
clinical videos, recorded with numerical video cameras
used in conjunction with optical 3D systems [6]. These
assessment methods are frequently used, however, they
have their disadvantages; observational/video gait analysis
was found to be inaccurate [7–9], 3D gait analysis systems
require more time, technical expertise and equipment
than is available in the average physiotherapy department
and are costly [10]. Due to these drawbacks, wireless
inertial sensors, which are wearable sensor devices (WSD)
are now used in gait assessment. WSDs are electronic
devices that are worn on the surface of the skin, where
they detect, analyze, and transmit information concerning
body signals. WSDs are easy to use, lightweight and costeffective. Since these devices are wireless, unrestricted
movement is enabled [11].
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The BTS G-WALK sensor system (G-Walk) determines
spatiotemporal parameters as well as all pelvic movement
(rotation, tilt and obliquity) during gait. The G-Walk, is a
WSD which is placed on an elastic belt and worn on the
waist of the person being evaluated. The device is placed on
the waist with the center of the device at the fifth lumbar
vertebrae and the patient is completely free to walk, run
and jump [11]. The G-Walk can be seen in Figure 1. The
system worn by the subject provides a series of parameters
that analyze various movements including walking,
running and jumping. The acquired data is transmitted to a
computer through a Bluetooth connection. For the analysis,
all measurements are calculated based on the person’s
height and movements. Therefore, it is necessary to enter
the height of the person prior to assessment. The height of
the subjects is used by the calculation algorithm to properly
identify the gait parameters. The software used is BTS
G-Studio. G-Studio is a simple and easy-to-use software
that can manage different acquisitions and automatically
elaborate and report different analysis protocols [12]. At the
end of each analysis a report containing all the parameters
is created automatically by the software.
The G-Walk was recently introduced as a multipurpose
testing and treatment device for the assessment of gait.
Before using such devices for clinical interpretation, the
reliability must be investigated. In literature there is one
study evaluating the reliability of the G-Walk. In this study
by De Ridder et al., the concurrent validity of the G-Walk
on gait parameters in healthy subjects was assessed.
They have concluded that, the G-Walk is reliable for all
measured spatiotemporal parameters and has excellent
concurrent validity for speed, cadence, stride length, and
stride duration [11]. However, this study only focuses on
healthy subjects making it impossible to generalize the
results for specific populations. It is unknown whether the
G-Walk is a reliable clinical assessment tool for children
with CP. The measurements should be reproducible,
stable, accurate, capable of distinguishing between normal
and abnormal conditions. As a portable low-cost device,
G-Walk may be beneficial in the assessment of gait in CP,
may assist in observational gait analysis and investigating
the gait pattern progression in the clinic. Therefore,
the purpose of this study was to confirm the test-retest
reliability of a commercially available body-worn sensor
‘BTS G-WALK sensor system’ for spatiotemporal gait
parameters in children with CP.
2. Materials and methods
2.1. Participants
Fifty-four children (25 females, 29 males) completed the
test-retest protocol with 5 days between tests. Children
between 5-15 years of age who were in level I (able to
walk in all settings with some balance and coordination

Figure 1. The G-Walk is placed on an elastic belt and worn on
the waist.

impairments) or level II (walking is limited in some settings)
according to the Gross Motor Function Classification
System (GMFCS), had spastic CP on one (unilateral CP) or
two sides (bilateral CP) of the body, could walk unassisted
and could cooperate were included in the study. Children
in GMFCS level I and II were included in this study because
children in these levels were able to walk without support.
The demographics and functional characteristics of the
children can be seen in Table 1. Those who had received
botulinum toxin injections in the past 6 months or those
who had undergone an orthopedic surgery involving the
lower extremities were excluded from the study. Before
recruiting children for our study, a power analysis was
performed. The sample size was calculated as 53 patients
by using G-power version 3.1.9.5. according to the study
by De Ridder et al. (effect size 0.17, α error probability =
0.05, and 80% power) [11]. Informed consent forms were
obtained from the patients and their caregivers stating that
they were willing to participate in the study. This study was
approved by the ethical committee of X University and the
authors conformed to the ethical guidelines of the 1975
Declaration of Helsinki.
2.2. Study design and procedures
This study was a cross-sectional design which included
patients with cerebral palsy who could walk independently.
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Table 1. Demographic and functional characteristics of children.
All children (n: 54)
Mean (SD)

GMFCS Level I

GMFCS Level II

11/17

18/8

Range

Sex (male/female)
Height (cm)

133.3 (18.91)

113-168

136.22 (21.93)

135.23 (17.52)

Weight (kg)

30.28 (14.28)

13-60

31.06 (14.48)

3..09 (16.36)

Age (year)

9.19 (3.49)

5-15

9.56 (4.10)

9.77 (3.22)

Topographical Classification

(n)

(n)

(n)

Unilateral involvement

32

26

6

Bilateral involvement

22

2

20

SD: Standard Deviations; GMFCS: Gross Motor Function Classification System.

Upon arrival at the first test session, the caregivers of the
participants filled out informed consent and medical
history form that included demographic information
and answered questions determining inclusion/exclusion
criteria for the study.
The gait parameters of the participants were evaluated
using the G-Walk sensor system (BTS G-Walk BTS
Bioengineering Company, Italy). G-Walk is built with a
triaxial accelerometer 16 bit/axes with multiple sensitivity,
a triaxial magnetometer 13 bit (±1200 μT) and a triaxial
gyroscope 16 bit/axes with multiple sensitivity (±250,
±500, ±1000, ±2000°/s). All data were collected using a
sampling frequency of 100 Hz. The device is placed on
an elastic belt and worn on the waist of the person being
evaluated, with the center of the device at the fifth lumbar
vertebrae [11]. To ensure the correct placement of the
device, the L4-L5 intervertebral space was palpated via
the posterior superior iliac spines. After the G-Walk was
placed, the children were asked to walk calmly at normal
speed, on a 7-meter track and to return to the starting
position. The boundaries of the track were determined
with colored lines. The examiners walked alongside the
children when necessary to ensure safety and maintain
walking velocity. A successful trial was characterized by
the participant completing the 7-meter track and returning
to the starting point. Any extra or unexpected movements
such as sneezing, coughing, stumbling or alterations in the
velocity (such as running or almost stopping) of the gait
deemed the trial unsuccessful, and thus was repeated.
The G-Walk provided quantitative analysis for the
performance of walking via spatiotemporal parameters
as well as pelvic movements during gait. It also enables
analysis of the pelvis angles, providing a functional analysis
of disorders in gait caused by neuromuscular diseases
[13,14]. The tilt of the pelvis in the sagittal plane in the
flexion-extension direction, the obliquity of the pelvis in
the coronal plane, the angles of rotation of movement in
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the transverse plane and the symmetry values of the right
and left sides were obtained. While the symmetry index
ranges from 0 to 100, a value closer to 100 indicates that
the gait is more symmetrical [15].
The children were tested after a practice trial, until we
obtained two successful trials per test session. The tests
were performed by the same examiner within an interval
of five days (test-retest). The second successful trial of each
session was included in the analysis.
2.3. Data analysis
Statistical analysis was conducted using the SPSS 22
computer software system. The variables were investigated
using analytical methods (Kolmogorov-Smirnov test) to
determine whether or not they are normally distributed.
Descriptive analyses were presented using means and
standard deviations (SD) for normally distributed
variables. Systematic differences were identified using
a paired T-test. Statistical significance for this study is
based on the p < 0.05 level. For the reliability, test-retest
analysis intra-class correlation coefficient (ICC) with
absolute agreement and 95% confidence interval (CI) were
determined between the first and second assessment. The
minimal detectable change (MDC), also referred to as the
“smallest detectable difference,” is an absolute measure of
reliability, which accounts for various sources of variability
in defining a confidence interval in units of the measure.
MDC is the smallest change you can measure above
this systematic error. It is important to calculate MDC
because the MDC is the minimum amount of change in a
subject’s score that ensures the change is not the result of
measurement error. MDC was calculated by multiplying
the SD of the difference with 1.96. When evaluating
interventions, the pre-post difference must be larger than
the MDC to express real improvement [16]. The standard
error of measurement (SEM) also provides a measure of
variability but was primarily used for calculating the MDC.
SEM values were calculated as follows: SEM = SD × √(1 –
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ICC), with SD representing the standard deviation of the
measure [16]. The ICC values were defined as; higher than
0.81 was almost perfect, 0.61–0.80 was high, 0.41–0.60 was
moderate, 0.21–0.40 was fair [17].
3. Results
Data analysis was performed with the data obtained
from 54 participants and the demographic statistics are

shown in Table 1. Mean and SD values of test and retest
G-Walk measurements of affected and less affected sides
are presented in Table 2. Table 3 demonstrates ICC, 95%
CI, SEM, and MDC. According to the analysis, ICC
varied from 0.799 to 0.977 in all of the gait parameters.
The statistical analysis showed that all G-Walk parameters’
measurements had almost perfect test-retest reliability.
There was no significant difference between test and retest

Table 2. Means and standard deviations of measurements.
Test
Mean (SD)

Retest
Mean (SD)

P

Cadence (steps/min)

121.1 (11.9)

120.5 (12.1)

0.501

Speed (m/s)

1.19 (0.24)

1.17 (0.25)

0.439

Affected side

1.02 (0.11)

1.02 (0.1)

0.813

Less affected side

1.02 (0.11)

1.03 (0.11)

0.409

Affected side

1.20 (0.24)

1.19 (0.25)

0.154

Less affected side

1.20 (0.25)

1.19 (0.25)

0.276

Affected side

94.41 (16.77)

92.75 (15.40)

0.106

Less affected side

94.32 (16.69)

92.92 (15.23)

0.150

Affected side

50.50 (2.86)

50.53 (2.92)

0.912

Less affected side

49.46 (2.71)

49.47 (2.92)

0.984

Affected side

60.72 (3.23)

60.74 (3.09)

0.941

Less affected side

62.49 (3.32)

62.49 (3.20)

0.986

Affected side

39.28 (3.23)

39.25 (3.09)

0.926

Less affected side

37.49 (3.35)

37.46 (3.22)

0.338

Affected side

10.81 (2.40)

10.96 (2.26)

0.607

Less affected side

12.29 (2.45)

12.09 (2.43)

0.373

Affected side

37.61 (3.30)

37.70 (3.33)

0.815

Less affected side

39.43 (3.32)

39.48 (3.16)

0.848

Affected side

11.46 (3.06)

11.52 (2.86)

0.832

Less affected side

11.39 (3.21)

11.57 (3.01)

0.497

Gait cycle duration (s)
Stride length (m)
% Stride length (% height)
Step length (% str length)
Stance phase (% cycle)
Swing phase (% cycle)
First double support phase (% cycle)
Single support phase (% cycle)
Elaborated steps
Gait cycle symmetry index
Pelvic girdle
angles

89.07 (8.70)

89.61 (6.88)

0.509

Tilt symmetry index (anterior/posterior)

51.80 (25.32)

48.29 (26.29)

0.227

Obliquity symmetry index (up/down)

92.83 (4.93)

92.26 (5.69)

0.700

Rotation symmetry index (intra/extra)

94.86 (6.45)

95.06 (4.91)

0.737

SD: Standard Deviations, min: Minute, s: Second, m: Meter, Analysis Duration (s): Duration of the whole trial,
Cadence (steps/min): Number of steps in a min, Speed (m/s): Average walking speed, Gait cycle duration (s):
Average value of the time interval between two consecutive heel strikes of the same foot, Stride length (m): Average
value of distances between each initial contact and the next one of the same side, % Stride length (%height): Stride
length normalized over the height of the subject, Step length (% str. length): Average value of distances between each
initial contact and the next one of the contralateral side, Stance phase (% cycle): average value of the duration of the
right and left foot support phase as percentage of the gait cycle, Swing phase (% cycle): Average value of the duration
of the right and left swing phase as percentage of the gait cycle, Double support phase (% cycle): Average value of the
duration of the phase in which both feet are in stance position as percentage of the gait cycle, Single support phase
(% cycle): Average value of the duration of the phase in which only one foot is in stance position as percentage of the
gait cycle, Elaborated steps: Number of strides considered in the analysis.
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Table 3. ICC, SEM, and MDC values of measurements.
95% CI
Test

ICC*

Cadence (steps/min)
Speed (m/s)

MDC

0.951

3.50

9.7

Upper
bound

0.915

0.854

0.941

0.898

0.966

0.29

0.8

Affected side

0.926

0.872

0.957

0.28

0.78

Less affected side

0.927

0.875

0.958

0.28

0.78

Affected side

0.974

0.955

0.985

0.19

0.57

Less affected side

0.977

0.960

0.986

0.18

3.27

Affected side

0.942

0.900

0.966

3.87

10.73

Less affected side

0.948

0.910

0.970

3.64

10.09

Affected side

0.844

0.730

0.909

1.14

3.16

Less affected side

0.850

0.741

0.913

1.09

3.02

Affected side

0.866

0.769

0.922

1.16

3.22

Less affected side

0.864

0.765

0.921

1.20

3.33

Affected side

0.865

0.766

0.922

1.16

3.22

Less affected side

0.864

0.764

0.922

1.21

3.35

Affected side

0.799

0.653

0.883

1.04

2.88

Less affected side

0.876

0.788

0.928

0.86

2.38

Affected side

0.847

0.736

0.911

1.30

3.6

Less affected side

0.873

0.781

0.927

1.15

3.19

Affected side

0.885

0.801

0.933

1.01

2.8

Less affected side

0.887

0.805

0.934

1.05

2.91

0.832

0.710

0.902

3.19

2.84

Tilt symmetry index (anterior/posterior)

0.954

0.916

0.974

5.53

15.33

Obliquity symmetry index (up/down)

0.887

0.804

0.934

1.78

4.93

Rotation symmetry index (intra/extra)

0.830

0.706

0.901

2.35

6.51

Gait cycle duration (s)
Stride length (m)
% Stride length (% height)
Step length (% str length)
Stance phase (% cycle)
Swing phase (% cycle)
First double support phase (% cycle)
Single support phase (% cycle)
Elaborated steps
Gait cycle symmetry index
Pelvic girdle
angles

SEM

Lower
bound

ICC: Intraclass correlation coefficient, CI: Confidence interval, SEM: Standard error measurements, MDC: Minimal detectable change,
min: Minute, s: Second, m: Meter, Analysis Duration (s): Duration of the whole trial, Cadence (steps/min): Number of steps in a min,
Speed (m/s): Average walking speed, Gait cycle duration (s): Average value of the time interval between two consecutive heel strikes
of the same foot, Stride length (m): Average value of distances between each initial contact and the next one of the same side, % Stride
length (%height): Stride length normalized over the height of the subject, Step length (% str. length): Average value of distances
between each initial contact and the next one of the contralateral side, Stance phase (% cycle): average value of the duration of the right
and left foot support phase as percentage of the gait cycle, Swing phase (% cycle): Average value of the duration of the right and left
swing phase as percentage of the gait cycle, Double support phase (% cycle): Average value of the duration of the phase in which both
feet are in stance position as percentage of the gait cycle, Single support phase (% cycle): Average value of the duration of the phase in
which only one foot is in stance position as percentage of the gait cycle, Elaborated steps: Number of strides considered in the analysis.

mean scores according to paired T-test for any G-Walk
measures, which indicates absence of any systematic bias
(p > 0.05).
4. Discussion
This study provided evidence related to test-retest
reliability and MDC values of the G-Walk sensor system
for spatiotemporal gait parameters in ambulatory children
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with CP who are in level I and II of the GMFCS. This study
is the first to assess the reliability of the G-Walk sensor
system in children with CP.
Test-retest reliability measures the extent of which
a testing measure is consistent and repeatable and it
involves validation of an assessment over multiple time
points. Reliability can be calculated as the ratio of a true
score variance to an observed score variance and is often
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Gait Cycle Duration (s)
Affected side
Less Affected Side

Affected side

% Stride Length (% height)
Affected side
Less Affected Side

Step Length (% str lenght)
Affected side
Less Affected Side

Stance Phase (% cycle)
Affected side
Less Affected Side

Swing Phase (% cycle)
Affected side
Less Affected Side

First Double Support Phase (% cycle)
Affected side
Less Affected Side

Single Support Phase (% cycle)
Affected side
Less Affected Side

Affected side

Stride Length (m)
Less Affected Side

Elaborated Steps
Less Affected Side

Figure 2. Unity line score plots for gait outcome measures (Test 1-Test 2). Dots on the unity line represent the identical test-retest score.
Higher scores on Test 1 appear beneath the line and higher scores on Test 2 appear above the line.
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expressed using a correlation coefficient, which ranges
from 0 to 1. The closer the coefficient is to 1, the more
reliable a testing measure is considered to be, implying that
the true score is assessed with little error variance [18].
The results show that the G-Walk had almost perfect
reliability in the assessment of spatiotemporal gait
parameters and pelvic girdle angles in children with
CP. The reliability of the device on spatiotemporal gait
parameters and pelvic girdle angles reflects the devices’
ability to provide consistent test-retest measurements.
The reliability levels were calculated using ICCs. In
the reliability analysis, the ICC value was above 70%,
indicating an acceptable confidence level. The ICC
values ranged from 0.799 to 0.977 between consecutive
measurements performed in five days in terms in all of
the gait parameters. According to the ICC values, the
reliability of the G-Walk was confirmed in children with
CP. However, when the unity line score plots (Figure 2 and
3) were investigated, it can be seen that almost all plots
had approximately 45° slope with the exception of less
affected side swing phase and pelvic obliquity symmetry
index score. As it can be seen in the respective plots, one
subject in each variable has deviated from the mean and
we believe the decrease in the slope of these plots is due to
the values of the deviated subject.
MDC values can help in identifying a true change in
measured performance that is beyond random variations

[19]. As a derivative of the intra-class correlation and
the standard deviation of the scores, the MDC value
provides understanding of the psychometrics of the
outcome measure. In this study, the MDC95 for the G-Walk
parameters show that the G-Walk has little measurement
error. High MDC values may raise concerns regarding
the accuracy of the outcome measure. For example, high
MDC values may show that the outcome measure itself
is not specific enough to measure the true capacity, the
assessed capacity is not stable from day to day, or that the
measured performance is affected by other factors [20,21].
The SEM is a reliability measure that assesses response
stability. The SEM is used to estimate the standard error in
a set of repeated scores. A gait analysis must be applicable
in a clinical setting in order for it to be effective. Thus, it
needs to be easy to apply in a variety of life situations and
it needs to be reliable [22].
De Ridder et al. have investigated the concurrent
validity of the G-walk on gait parameters in healthy
subjects. They have concluded that, the G-Walk has
excellent concurrent validity for speed, cadence, stride
length, and stride duration. Regarding the reliability of the
device, the authors have stated that G-Walk is reliable for
all measured spatiotemporal parameters. Similar to their
findings, we have also found the BTS G-Walk has perfect
reliability for measuring these parameters. In addition to
the study by De Ridder et al., we have also found that the

Pelvic Girdle Angles
Tilt Symmetry Index
(anterior/posterior)

Obliquity Symmetry Index
(up/down)

Rotation Symmetry Index
(intra/extra)

Gait Cycle Symmetry Index

Cadence (steps/min)

Speed (m/s)

Figure 3. Unity line score plots for basic gait mobility outcome measures (Test 1-Test 2). Dots on the unity line represent identical testretest score. Higher scores on Test 1 appear beneath the line and higher scores on Test 2 appear above the line.

664

VOLKAN-YAZICI et al. / Turk J Med Sci
reliability of the G-Walk on measuring pelvic angles was
perfect. In light of the results presented here, a gait analysis
carried out with the G-Walk system is a reliable method to
assess gait in children with CP in a clinical setting.
Limitations of this study are that the age range of
participants included in the study was limited to 5–15 and
therefore cannot be generalized to the adult CP population.
Also, this study did not include participants who had
ataxic, dyskinetic or nonclassifiable type CP. Children
who had severe cognitive impairment were not included
in the study due to lack of cooperation. This study only
aimed to investigate the reliability of the G-Walk. Further
investigation regarding the validity of this device must be
performed.
In conclusion, the current study established test-retest
reliability and MDC values in children with CP who could

walk independently. Results show that the G-Walk is reliable
for gait assessment in this population.
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